Historical BackgroundThe development of the Rome criteria was an international effort to create scientific data to aid in the diagnosis and treatment of functional gastrointestinal disorders.
In 1962, Chaudhary and Truelove published a study of patients with irritable bowel syndrome (IBS) in Oxford, UK, which was the first attempt to classify functional gastrointestinal disorders. The methods and findings of this study have had a profound influence to this day and formed the basis for the later Roman standards.
Then in 1978, Kenneth Heaton and his team developed the "Manning Criteria," which focused on the types of IBS and its main symptoms. This played an important role in the symptomatic classification of IBS in the subsequent Rome criteria.
The evolution of the Rome criteria represents a progressive understanding and scientific management of functional gastrointestinal disorders.
The evolution of the Rome criteria dates back to 1989, when the first consensus-based diagnostic criteria for IBS were established. Subsequently, in 1994, FGIDs were further subdivided and the book Functional Gastrointestinal Disorders: A Multinational Consensus on Diagnosis, Pathophysiology, and Treatment was published, which laid the foundation for Rome I.
The main framework of the Rome I standard has undergone several updates in the following years, including Rome II (1999) and Rome III (2006). Each update has systematically improved the original standard. Sexual perfection. Not only have the criteria for adult patients been strengthened, but even pediatric diagnostic criteria have been incorporated.During the evolution of these standards, the international community has paid more and more attention to the scientific research and clinical application of functional gastrointestinal disorders.
Published in 2016, the Rome IV criteria build on research from the past 20 years and include detailed specifications for 33 functional gastrointestinal disorders in adults and 17 in children. This standard further considers the etiology, epidemiology, and psychosocial characteristics of the disease and provides specific diagnostic and treatment recommendations.
During this process, the Rome Foundation explored a new diagnostic model with multidimensional clinical characteristics (MDCP) as the core, which not only improved the diagnosis and treatment level of medical workers, but also provided scientific support for the individualized treatment of patients. .
Since its founding in 1996, the Rome Foundation has been dedicated to advancing the scientific knowledge and clinical management of gastrointestinal diseases. This nonprofit organization advances the understanding and research of functional gastrointestinal disorders by bringing together scientists and clinicians from around the world.
Several agencies, including the US Food and Drug Administration (FDA), are increasingly recognizing the importance of the Rome criteria to clinical practice.
Today, the Rome criteria have become the globally accepted basis for the diagnosis of functional gastrointestinal disorders. Future research and clinical practice still need to continue to explore and improve based on these criteria. With the advancement of science and technology, new clinical data and research results will undoubtedly lead to the next update of the standards.
In this process of continuous evolution, how to better use these standards in clinical applications to improve the quality of life of patients will be a proposition worth pondering?